 |
| Source: Center for Biotechnology website |
Address: New Delhi 110067 India
Website: http://www.jnu.ac.in/
Phone: +91-11-26107676; 26167557
Subordinate to: None
Size: Eight faculty members, two research associates, and 35 students in the Master's program.
Primary Function: The center develops human resources for industry, medicine, and agriculture.
History:
The center was established in 1985 under joint sponsorship of the University Grants Commission (UGC) and the Department of Biotechnology, Government of India. During that same year, a Master's of Science in Biotechnology was offered and funded by the Department of Biotechnology, Government of India.
Activities:
In November 2001, Panacea Biotec agreed to produce a new anthrax vaccine based on technology developed by Professor Rakesj Bhatnagar at the Center for Biotechnology and in collaboration with Dr. Yogender Singh and his associates at the Center for Biochemical Techonology.
The center emphasizes the teaching of physicochemical aspect of biology as well as cell biology, biochemistry, biophysics, microbiology, molecular biology, biostatistics and computer applications. In the later semesters, specialized courses in enzymology, biochemical engineering, genetic engineering and immunotechnology are offered.
The center also works closely with other institutions such as the National Institute of Immunology, All India Institute of Medical Sciences, and the Biochemical Engineering Centre of IIT, Delhi.
Key Sources: Pankaj Gupta et al., "Expression and Purification of the Recombinant Lethal Factor of Bacillus Anthracis," Infection and Immunity, February 1998, p. 862; Center for Biotechnology: Jawaharlal Nehru University, <http://www.angelfire.com/ct/cbtjnu/index.html>.
 |
| |
Updated September 2003 |
|
|
